Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy

Completed

Conditions studied: Breast Cancer

In brief

This study is being done to evaluate if MR spectroscopy will give us more information about whether or not your chemotherapy will work for you. Spectroscopy is a special set of pictures taken with Magnetic Resonance Imaging (MRI) that gives us information about the chemical composition of your breast cancer.

Key facts

Study ID

NCT00580086

Run by

Memorial Sloan Kettering Cancer Center

People needed

19

Starts

2006-11-01

Expected to finish

2009-12-01

Last updated by the study team

2009-12-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients need to be ≥ 18 years of age
• Patients with biopsy confirmed adenocarcinoma of the breast, scheduled to receive neoadjuvant chemotherapy prior to surgical management.

You may not qualify if…

• Patients who would normally be excluded from undergoing an MRI examination include:
• Patients with a pacemaker, aneurysm clip or any other condition that would warrant avoidance of a strong magnetic field
• Patients who are pregnant
• Patients who are unable to comply or complete the MRI exam such as patients with claustrophobia and patients who have electrically, magnetically, or mechanically activated implants, such as heart pacemakers, certain types of artificial joints, inner ear implants, eye implants, or certain surgical clips used in vascular surgery.
• Patients who are not candidates for neoadjuvant chemotherapy

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.